Financial Services
OpGen Inc.(CFOR)
Live Price
Offline$3.50
+75.00% today
1Y Change
-58.52%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $230.00M
- Revenue Growth
- +52.0%
- EPS Growth
- +105.9%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
OpGen Inc. (CFOR) is a Financial Services stock with a market cap of $230.00M and listed on OTC. The stock last traded around $3.50 and down 58.5% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +52.0%, EPS growth of +105.9%, a dividend yield of 0.0%. What stands out right now is revenue +52.0%, EPS +105.9%, free cash flow +67.8% with operating margin 73.1% and ROIC 52.5%. Valuation already assumes a fairly strong business story at P/E 33.8 and price/sales 25.9. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines CFOR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+52.0% vs +3.4% peer median
Operating Margin
Above sector median
+73.1% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 2, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +52.0% and EPS at +105.9%, with operating margin around 73.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +8.3% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 2, 2026 | โ | -0.0% | -2.1% | -100.0% |
2025 Nov 19, 2025 | โ | -10.7% | +27.0% | +161.5% |
2025 Aug 21, 2025 | +159.5% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
CFOR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CFOR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CFOR Max Drawdown
-100.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CFOR and SPY.
Company Overview
OpGen Inc.
OTC
OpGen Inc. is a precision medicine company that has repositioned its business to focus on digital investment banking and financial technology through its subsidiary CapForce International Holdings Ltd. It offers listing sponsorship and capital market services to mid-sized growth-stage private companies worldwide targeting public market listings with market capitalizations between USD1 billion and USD10 billion. CapForce is developing a next-generation global digital investment banking platform to support cross-border securities trading, AI-driven robo-advisory for investment banking and asset management, and FinTech-enabled cap table management solutions. These services aim to facilitate efficient access to public markets and advanced financial tools for growth-oriented firms. Previously centered on molecular microbiology solutions for life-threatening infectious diseases, including products like Unyvero systems and Acuitas AMR Gene Panel tests, as well as laboratory and collaboration services, OpGen Inc. now emphasizes its current fintech and capital markets segments. Incorporated in 2001 and headquartered in Rockville, Maryland, OpGen Inc. operates in the evolving intersection of healthcare diagnostics and financial services.
- Leadership
- Mr. Honjian Tan
- Employees
- 1
- Street Address
- 23219 Stringtown Road, Suite 300
- Mailing
- Clarksburg, MD, 20871
- Region
- Clarksburg, MD, United States
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 33.8
- EV/EBITDA
- 32.8
- Price/Sales
- 25.9
- Price/Book
- 22.8
Growth
- Revenue
- +52.0%
- EPS
- +105.9%
- Free Cash Flow
- +67.8%
Profitability
- Gross Margin
- 98.9%
- Operating Margin
- 73.1%
- Net Margin
- 76.0%
- ROE
- 77.6%
- ROIC
- 52.5%
Balance Sheet
- Debt/Equity
- 0.37
- Current Ratio
- 7.06
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.